Sally Susman, Pfizer's Communications and Policy Chief, is set to leave her role at the end of 2025. She was instrumental in building public trust during the COVID-19 vaccine's rapid development in 2020. Susman advocated for transparency and involved reporters in clinical trials to foster confidence in Pfizer's processes. Her departure coincides with the company restructuring due to declining demand for its COVID-19 vaccine and other financial challenges. Susman's responsibilities will be reassigned among top executives as she continues on the board of directors.
In early 2020, Pfizer Communications and Policy Chief Sally Susman was stunned when the head of the pharmaceutical company revealed plans to bring a COVID-19 vaccine forward by the end of that year.
Susman described the months that followed as a career-defining opportunity to help build people's trust in the company during an extraordinary time of uncertainty and fear.
She pushed for Pfizer to be as transparent as possible about its work, such as by taking steps to safely embed reporters into its clinical trials.
Susman's pending exit from Pfizer comes as the company is undergoing a restructuring effort due to a number of factors, including slowing demand for its COVID-19 vaccine.
Collection
[
|
...
]